http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-01-15Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathiesRegulation (EC) No 999/2001 of the European Parliament and of the CouncilRegulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathiesKing's Printer of Acts of Parliamenthttps://webarchive.nationalarchives.gov.uk/eu-exit/https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02001R0999-20080115texttext/xmlen2024-05-192008-01-15 ANNEX X REFERENCE LABORATORIES, SAMPLING AND LABORATORY ANALYSIS METHODS CHAPTER C <Substitution ChangeId="O015001M004" CommentaryRef="c000010">Sampling and laboratory testing</Substitution> 1. <Substitution ChangeId="O015001M004" CommentaryRef="c000010"> <Substitution ChangeId="O024001M016" CommentaryRef="c000005">Sampling</Substitution> </Substitution>

Any samples intended to be examined for the presence of a TSE shall be collected using the methods and protocols laid down in the latest edition of the Manual for diagnostic tests and vaccines for Terrestrial Animals of the International Office for Epizooties (IOE/OIE) (the Manual). In addition, or in the absence, of OIE methods and protocols, and to ensure that sufficient material is available, the competent authority shall ensure the use of sampling methods and protocols in accordance with guidelines issued by the Community Reference Laboratory. In particular the competent authority shall collect the appropriate tissues, according to the available scientific advice and the guidelines of the Community Reference Laboratory, in order to ensure the detection of all known strains of TSE in small ruminants and shall keep at least half of the collected tissues fresh but not frozen until the result of the rapid test is negative. Where the result is positive or inconclusive the residual tissues must be processed in accordance with the Community reference laboratory guidelines.

The samples shall be correctly marked as to the identity of the sampled animal.

2. <Substitution ChangeId="O015001M004" CommentaryRef="c000010">Laboratories</Substitution>

Any laboratory examination for TSE shall be carried out in laboratories approved for that purpose by the competent authority.

3. <Substitution ChangeId="O015001M004" CommentaryRef="c000010">Methods and protocols</Substitution> 3.1. <Substitution ChangeId="O015001M004" CommentaryRef="c000010">Laboratory testing for the presence of BSE in bovine animals</Substitution> (a) <Substitution ChangeId="O015001M004" CommentaryRef="c000010">Suspect cases</Substitution>

Samples from bovine animals sent for laboratory testing pursuant to the provisions of Article 12(2) shall be subject to a histopathological examination as laid down in the latest edition of the Manual, except where the material is autolysed. Where the result of the histopathological examination is inconclusive or negative or where the material is autolysed, the tissues shall be subjected to an examination by one of the other diagnostic methods laid down in the Manual (immunocytochemistry, immuno-blotting or demonstration of characteristic fibrils by electron microscopy). However, rapid tests cannot be used for this purpose.

If the result of one of those examinations is positive, the animals shall be regarded a positive BSE case.

(b) <Substitution ChangeId="O015001M004" CommentaryRef="c000010">BSE monitoring</Substitution>

Samples from bovine animals sent for laboratory testing pursuant to the provisions of Annex III, Chapter A, Part I (Monitoring in bovine animals) shall be examined by a rapid test.

When the result of the rapid test is inconclusive or positive, the sample shall immediately be subject to confirmatory examinations in an official laboratory. The confirmatory examination shall start by a histopathological examination of the brainstem as laid down in the latest edition of the Manual, except where the material is autolysed or otherwise not suitable for examination by histopathology. Where the result of the histopathological examination is inconclusive or negative or where the material is autolysed, the sample shall be subjected to an examination by one of the other diagnostic methods referred to in (a).

An animal shall be regarded a positive BSE case, if the result of the rapid test is positive or inconclusive, and either

the result of the subsequent histopathological examination is positive, or the result of another diagnostic method referred to in (a) is positive.

3.2. <Substitution ChangeId="O015001M004" CommentaryRef="c000010">Laboratory testing for the presence of TSE in ovine and caprine animals</Substitution> (a) <Substitution ChangeId="O015001M004" CommentaryRef="c000010">Suspect cases</Substitution>

Samples from ovine and caprine animals sent for laboratory testing pursuant to the provisions of Article 12(2) shall be subject to a histopathological examination as laid down in the latest edition of the Manual, except where the material is autolysed. Where the result of the histopathological examination is inconclusive or negative or where the material is autolysed, the sample shall be subjected to an examination by immunocytochemistry, immuno-blotting or demonstration of characteristic fibrils by electron microscopy, as laid down in the Manual. However, rapid tests cannot be used for this purpose.

If the result of one of those examinations is positive, the animal shall be regarded a positive scrapie case.

(b) <Substitution ChangeId="O015001M004" CommentaryRef="c000010"> <Substitution ChangeId="O024001M017" CommentaryRef="c000005">TSE monitoring</Substitution> </Substitution>

Samples from ovine and caprine animals sent for laboratory testing pursuant to the provisions of Annex III, Chapter A, Part II (Monitoring in ovine and caprine animals) shall be examined by a rapid test using the appropriate methods and protocols, according to the available scientific advice and the guidelines of the Community Reference Laboratory, in order to ensure the detection of all known strains of TSE.

When the result of the rapid test is inconclusive or positive, the sampled tissues shall immediately be sent to an official laboratory for confirmatory examinations by immunocytochemistry, immuno-blotting or demonstration of characteristic fibrils by electron microscopy, as referred to in (a). If the result of the confirmatory examination is negative or inconclusive, additional confirmatory testing shall be carried out according the guidelines of the Community reference laboratory.

If the result of one of the confirmatory examination is positive, the animal shall be regarded a positive TSE case.

(c) <Substitution ChangeId="O015001M004" CommentaryRef="c000010">Further examination of positive scrapie cases</Substitution>

Primary molecular testing with a discriminatory immuno-blotting Samples from clinical suspect cases and from animals tested in accordance with Annex III, Chapter A, Part II, points 2 and 3 which are regarded as positive scrapie cases following the examinations referred to in points (a) or (b), or which display characteristics which are deemed by the testing laboratory to merit investigation, shall be forwarded for further examination by a primary molecular typing method to: Agence Française de Sécurité Sanitaire des Aliments, Laboratoire de pathologie bovine, 31, avenue Tony Garnier, BP 7033, F-69342, Lyon Cedex, France , or Veterinary Laboratories Agency, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom , or to a laboratory, appointed by the competent authority, which has participated successfully in proficiency testing organised by the Community Reference Laboratory for the use of a molecular typing method, or on a provisional basis until 1 May 2005 , the laboratories approved for this purpose by the CRL panel of experts. Ring trial with additional molecular testing methods Samples from scrapie cases in which the presence of BSE cannot be excluded according to the guidelines issued by the Community Reference Laboratory by the primary molecular testing referred to in (i), shall be forwarded immediately to the laboratories listed in point (d) after consultation with the Community Reference Laboratory, and with all the relevant information available. They shall be submitted to a ring trial with at least: a second discriminatory immuno-blotting, a discriminatory immunocytochemistry, and a discriminatory ELISA (Enzyme linked ImmunoSorbent Assay) Further testing of positive TSE samples detected in infected flocks on the same holding shall be carried out at least on the first two positive TSE cases detected every year following the index case.

The results shall be interpreted by the Community Reference Laboratory assisted by a panel of experts including a representative of the relevant National Reference Laboratory. The Commission shall be informed immediately about the outcome of that interpretation. Samples indicative for BSE by three different methods and samples inconclusive in the ring trial shall be further analysed by a mouse bioassay for final confirmation.

Further testing of samples taken from infected flocks on the same holding in accordance with the provisions of Annex III, Chapter A, Part II, point 5, shall be carried out in accordance with the advice of the Community Reference Laboratory, after consultation with the relevant National Reference Laboratory.

(d) <Substitution ChangeId="O015001M004" CommentaryRef="c000010">Laboratories approved for performing further examination by molecular typing methods</Substitution>

The laboratories approved for further molecular typing are:

Agence Française de Sécurité Sanitaire des Aliments Laboratoire de pathologie bovine 31, avenue Tony Garnier BP 7033 F-69342 Lyon Cedex Centre CEA Fontenay-aux-Roses, BP 6 F-92265 Fontenay-aux-Roses Cedex Service de Pharmacologie et d’Immunologie Centre CEA Saclay, bâtiment 136 F-91191 Gif-sur-Yvette Cedex Veterinary Laboratories Agency Woodham Lane New Haw Addlestone Surrey KT15 3NB United Kingdom

3.3. <Substitution ChangeId="O015001M004" CommentaryRef="c000010">Laboratory testing for the presence of TSEs in species other than those referred to in points 3.1. and 3.2.</Substitution>

Where methods and protocols are established for tests carried out to confirm the suspected presence of a TSE in a species other than bovine, ovine and caprine, they shall include at least a histopathological examination of brain tissue. The competent authority may also require laboratory tests such as immunocytochemistry, immuno-blotting, demonstration of characteristic fibrils by electron microscopy or other methods designed to detect the disease associated form of the prion protein. In any case at least one other laboratory examination shall be carried out if the initial histopathological examination is negative or inconclusive. At least three different examinations shall be carried out in the event of the first appearance of the disease.

In particular, where BSE is suspected in a species other than bovine animals, samples shall be submitted for strain-typing, where possible.

4. <Substitution ChangeId="O015001M004" CommentaryRef="c000010"> <Substitution ChangeId="O026001M003" CommentaryRef="c000024">Rapid tests</Substitution> </Substitution>

For the purposes of carrying out the rapid tests in accordance with Articles 5(3) and 6(1), the following methods shall be used as rapid tests for the monitoring of BSE in bovine animals:

immuno-blotting test based on a Western blotting procedure for the detection of the Proteinase K resistant fragment PrP Res (Prionics-Check Western test), chemiluminescent ELISA test involving an extraction procedure and an ELISA technique, using an enhanced chemiluminescent reagent (Enfer test & Enfer TSE Kit version 2.0, automated sample preparation), microplate based immunoassay for the detection of PrP Sc (Enfer TSE Version 3), sandwich immunoassay for PrP Res carried out following denaturation and concentration steps (Bio-Rad Te-SeE test), microplate based immunoassay (ELISA) which detects Proteinase K resistant PrP Res with monoclonal antibodies (Prionics-Check LIA test), conformation-dependent immunoassay, BSE antigen test kit (Beckman Coulter InPro CDI kit), chemiluminescent ELISA for qualitative determination of PrP Sc (CediTect BSE test), immunoassay using a chemical polymer for selective PrP Sc capture and a monoclonal detection antibody directed against conserved regions of the PrP molecule (IDEXX HerdChek BSE Antigen Test Kit, EIA), microplate based chemiluminescent immunoassay for the detection of PrP Sc in bovine tissues (Institut Pourquier Speed’it BSE), lateral flow immunoassay using two different monoclonal antibodies to detect Proteinase K resistant PrP fractions (Prionics Check PrioSTRIP), two-sided immunoassay using two different monoclonal antibodies directed against two epitopes presented in a highly unfolded state of bovine PrP Sc (Roboscreen Beta Prion BSE EIA Test Kit), sandwich ELISA for the detection of Proteinase K resistant PrP Sc (Roche Applied Science PrionScreen), antigen-capture ELISA using two different monocloncal antibodies to detect Proteinase K resistant PrP fractions (Fujirebio FRELISA BSE post-mortem rapid BSE Test).

For the purposes of carrying out the rapid tests in accordance with Articles 5(3) and 6(1), the following methods shall be used as rapid tests for the monitoring of TSEs in ovine and caprine animals:

conformation-dependent immunoassay, BSE antigen test kit (Beckman Coulter InPro CDI kit), sandwich immunoassay for PrP Res carried out following denaturation and concentration steps (Bio-Rad Te-SeE test), sandwich immunoassay for PrP Res carried out following denaturation and concentration steps (Bio-Rad Te-SeE Sheep/Goat test), chemiluminescent ELISA test involving an extraction procedure and an ELISA technique, using an enhanced chemiluminescent reagent (Enfer TSE Kit Version 2.0), microplate based immunoassay for the detection of PrP Sc (Enfer TSE Version 3), immunoassay using a chemical polymer for selective PrP Sc capture and a monoclonal detection antibody directed against conserved regions of the PrP molecule (IDEXX HerdChek BSE-Scrapie Antigen Test Kit, EIA), microplate based chemiluminescent immunoassay for the detection of PrP Sc in ovine tissues (POURQUIER’S-LIA Scrapie), immuno-blotting test based on a Western blotting procedure for the detection of the Proteinase K resistant fragment PrP Res (Prionics-Check Western Small Ruminant test), microplate based chemiluminescent immunoassay for the detection of Proteinase K resistant PrP Sc (Prionics Check LIA Small Ruminants).

In the case of all tests, sample tissue to which the test is to be applied must comply with the manufacturer’s instructions for use.

The producer of the rapid tests must have put in place a quality assurance system, approved by the Community Reference Laboratory (CRL) that ensures that the test performance does not change. The producer must provide the test protocol to the CRL.

Changes to rapid tests and to test protocols may be made only after prior notification to the CRL and provided that the CRL finds that the change does not alter the sensitivity, specificity or reliability of the rapid test. That finding shall be communicated to the Commission and to the national reference laboratories.

5. <Substitution ChangeId="O015001M004" CommentaryRef="c000010">Alternative tests</Substitution>

(To be defined)

Substituted by Commission Regulation (EC) No 727/2007 of 26 June 2007 amending Annexes I, III, VII and X to Regulation (EC) No 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance). Substituted by Commission Regulation (EC) No 36/2005 of 12 January 2005 amending Annexes III and X to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards epidemio-surveillance for transmissible spongiform encephalopathies in bovine, ovine and caprine animals (Text with EEA relevance). Substituted by Commission Regulation (EC) No 21/2008 of 11 January 2008 amending Annex X to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards the lists of rapid tests (Text with EEA relevance).
This XML file does not appear to have any style information associated with it. The document tree is shown below.
<Legislation xmlns="http://www.legislation.gov.uk/namespaces/legislation" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" DocumentURI="http://www.legislation.gov.uk/eur/2001/999/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999" NumberOfProvisions="29" RestrictEndDate="2008-04-26" xsi:schemaLocation="http://www.legislation.gov.uk/namespaces/legislation http://www.legislation.gov.uk/schema/legislation.xsd" SchemaVersion="2.0" RestrictStartDate="2008-01-15" RestrictExtent="E+W+S+N.I.">
<ukm:Metadata xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:ukm="http://www.legislation.gov.uk/namespaces/metadata">
<dc:identifier>http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-01-15</dc:identifier>
<dc:title>Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies</dc:title>
<dct:alternative>Regulation (EC) No 999/2001 of the European Parliament and of the Council</dct:alternative>
<dc:description>Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies</dc:description>
<dc:publisher>King's Printer of Acts of Parliament</dc:publisher>
<dc:source>https://webarchive.nationalarchives.gov.uk/eu-exit/https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02001R0999-20080115</dc:source>
<dc:type>text</dc:type>
<dc:format>text/xml</dc:format>
<dc:language>en</dc:language>
<dc:modified>2024-05-19</dc:modified>
<dct:valid>2008-01-15</dct:valid>
<atom:link rel="self" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-01-15/data.xml" type="application/xml"/>
<atom:link rel="http://www.legislation.gov.uk/def/navigation/resources" href="http://www.legislation.gov.uk/eur/2001/999/resources" title="More Resources"/>
<atom:link rel="http://www.legislation.gov.uk/def/navigation/act" href="http://www.legislation.gov.uk/eur/2001/999/2008-01-15" title="whole act"/>
<atom:link rel="http://www.legislation.gov.uk/def/navigation/introduction" href="http://www.legislation.gov.uk/eur/2001/999/introduction/2008-01-15" title="introduction"/>
<atom:link rel="http://www.legislation.gov.uk/def/navigation/signature" href="http://www.legislation.gov.uk/eur/2001/999/signature/2008-01-15" title="signature"/>
<atom:link rel="http://www.legislation.gov.uk/def/navigation/body" href="http://www.legislation.gov.uk/eur/2001/999/body/2008-01-15" title="body"/>
<atom:link rel="http://www.legislation.gov.uk/def/navigation/annexes" href="http://www.legislation.gov.uk/eur/2001/999/annexes/2008-01-15" title="annexes"/>
<atom:link rel="http://www.legislation.gov.uk/def/date/euexitday" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2020-01-31" title="2020-01-31"/>
<atom:link rel="http://www.legislation.gov.uk/def/date/euexitTransitionEnd" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2020-12-31" title="2020-12-31"/>
<atom:link rel="http://www.legislation.gov.uk/def/legislation/EffectsApplied" href="https://www.legislation.gov.uk/changes/applied/affected/eur/2001/999" title="Amended by UK"/>
<atom:link rel="alternate" type="application/rdf+xml" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-01-15/data.rdf" title="RDF/XML"/>
<atom:link rel="alternate" type="application/akn+xml" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-01-15/data.akn" title="AKN"/>
<atom:link rel="alternate" type="application/xhtml+xml" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-01-15/data.xht" title="HTML snippet"/>
<atom:link rel="alternate" type="text/html" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-01-15/data.htm" title="Website (XHTML) Default View"/>
<atom:link rel="alternate" type="text/csv" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-01-15/data.csv" title="CSV"/>
<atom:link rel="alternate" type="application/pdf" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-01-15/data.pdf" title="PDF"/>
<atom:link rel="alternate" type="application/akn+xhtml" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-01-15/data.html" title="HTML5 snippet"/>
<atom:link rel="http://purl.org/dc/terms/tableOfContents" hreflang="en" href="http://www.legislation.gov.uk/eur/2001/999/contents/2008-01-15" title="Table of Contents"/>
<atom:link rel="http://purl.org/dc/terms/replaces" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2007-07-17" title="2007-07-17"/>
<atom:link rel="http://purl.org/dc/terms/isReplacedBy" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-04-26" title="2008-04-26"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2005-01-01" title="2005-01-01"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2005-02-11" title="2005-02-11"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2005-03-09" title="2005-03-09"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2006-03-17" title="2006-03-17"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2007-07-17" title="2007-07-17"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-04-26" title="2008-04-26"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2009-03-19" title="2009-03-19"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2011-01-01" title="2011-01-01"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2012-11-17" title="2012-11-17"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2013-07-01" title="2013-07-01"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2015-01-01" title="2015-01-01"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2017-02-13" title="2017-02-13"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2020-11-19" title="2020-11-19"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2020-12-31" title="2020-12-31"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2022-11-16" title="2022-11-16"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C" title="current"/>
<atom:link rel="up" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/2008-01-15" title="Annex X"/>
<atom:link rel="prev" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/B/2008-01-15" title="Chapter; Annex X Chapter B"/>
<atom:link rel="prevInForce" href="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/B/2008-01-15" title="Chapter; Annex X Chapter B"/>
<atom:link rel="next" href="http://www.legislation.gov.uk/eur/2001/999/annex/XI/2008-01-15" title="Annex; Annex XI"/>
<atom:link rel="nextInForce" href="http://www.legislation.gov.uk/eur/2001/999/annex/XI/2008-01-15" title="Annex; Annex XI"/>
<ukm:EUMetadata>
<ukm:DocumentClassification>
<ukm:DocumentCategory Value="euretained"/>
<ukm:DocumentMainType Value="EuropeanUnionRegulation"/>
<ukm:DocumentStatus Value="revised"/>
</ukm:DocumentClassification>
<ukm:Year Value="2001"/>
<ukm:Number Value="999"/>
<ukm:EURLexIdentifiers>
<ukm:Cellar Value="3e840d31-5c99-4a94-b91b-f24f9a45202b"/>
<ukm:ELI Value="reg:2001:999:2008-01-15"/>
<ukm:CELEX Value="02001R0999-20080115"/>
</ukm:EURLexIdentifiers>
<ukm:EnactmentDate Date="2001-05-22"/>
<ukm:EURLexModified Date="2016-06-30T21:26:35Z"/>
<ukm:EURLexExtracted Date="2018-05-20T21:04:02Z"/>
<ukm:XMLGenerated Date="2020-12-11T20:25:49Z"/>
<ukm:XMLImported Date="2020-12-14T10:09:55Z"/>
<ukm:CreatedBy Label="Council of the European Union" URI="http://publications.europa.eu/resource/authority/corporate-body/CONSIL"/>
<ukm:CreatedBy Label="European Parliament" URI="http://publications.europa.eu/resource/authority/corporate-body/EP"/>
<ukm:EURLexMetadata>
<WORK xmlns="">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/3e840d31-5c99-4a94-b91b-f24f9a45202b</VALUE>
<IDENTIFIER>3e840d31-5c99-4a94-b91b-f24f9a45202b</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/reg/2001/999/2008-01-15</VALUE>
<IDENTIFIER>reg:2001:999:2008-01-15</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/02001R0999-20080115</VALUE>
<IDENTIFIER>02001R0999-20080115</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/consolidation/2001R0999%2F20080115</VALUE>
<IDENTIFIER>2001R0999/20080115</IDENTIFIER>
<TYPE>consolidation</TYPE>
</URI>
</SAMEAS>
<RESOURCE_LEGAL_ELI type="data">
<VALUE>http://data.europa.eu/eli/reg/2001/999/2008-01-15</VALUE>
</RESOURCE_LEGAL_ELI>
<WORK_PART_OF_COLLECTION_DOCUMENT type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/document-collection/CELEX</VALUE>
<IDENTIFIER>CELEX</IDENTIFIER>
<TYPE>document-collection</TYPE>
</URI>
<OP-CODE>CELEX</OP-CODE>
<IDENTIFIER>CELEX</IDENTIFIER>
<PREFLABEL>CELEX</PREFLABEL>
</WORK_PART_OF_COLLECTION_DOCUMENT>
<RESOURCE_LEGAL_HAS_TYPE_ACT_CONCEPT_TYPE_ACT type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/fd_030/VC</VALUE>
<IDENTIFIER>VC</IDENTIFIER>
<TYPE>fd_030</TYPE>
</URI>
<OP-CODE>VC</OP-CODE>
<IDENTIFIER>VC</IDENTIFIER>
<PREFLABEL>Consolidated text</PREFLABEL>
</RESOURCE_LEGAL_HAS_TYPE_ACT_CONCEPT_TYPE_ACT>
<IDENTIFIER type="data">
<VALUE>consolidation:2001R0999/20080115</VALUE>
</IDENTIFIER>
<CREATED_BY type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/corporate-body/CONSIL</VALUE>
<IDENTIFIER>CONSIL</IDENTIFIER>
<TYPE>corporate-body</TYPE>
</URI>
<OP-CODE>CONSIL</OP-CODE>
<IDENTIFIER>CONSIL</IDENTIFIER>
<PREFLABEL>Council of the European Union</PREFLABEL>
<ALTLABEL>Council</ALTLABEL>
<ALTLABEL>Council of the European Communities</ALTLABEL>
</CREATED_BY>
<ID_CELEX type="data">
<VALUE>02001R0999-20080115</VALUE>
</ID_CELEX>
<IDENTIFIER type="data">
<VALUE>02001R0999-20080115</VALUE>
</IDENTIFIER>
<WORK_DATE_DOCUMENT type="date">
<VALUE>2008-01-15</VALUE>
<YEAR>2008</YEAR>
<MONTH>01</MONTH>
<DAY>15</DAY>
</WORK_DATE_DOCUMENT>
<ELI type="data">
<VALUE>http://data.europa.eu/eli/reg/2001/999/2008-01-15</VALUE>
</ELI>
<DATE type="date">
<VALUE>2008-04-21</VALUE>
<YEAR>2008</YEAR>
<MONTH>04</MONTH>
<DAY>21</DAY>
</DATE>
<RESOURCE_LEGAL_CONSOLIDATED_BY_ACT_CONSOLIDATED type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/0e58fd4a-bc09-455b-8e41-cf42088509ef</VALUE>
<IDENTIFIER>0e58fd4a-bc09-455b-8e41-cf42088509ef</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/reg/2001/999/2008-04-26</VALUE>
<IDENTIFIER>reg:2001:999:2008-04-26</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/consolidation/2001R0999%2F20080426</VALUE>
<IDENTIFIER>2001R0999/20080426</IDENTIFIER>
<TYPE>consolidation</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/02001R0999-20080426</VALUE>
<IDENTIFIER>02001R0999-20080426</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
</RESOURCE_LEGAL_CONSOLIDATED_BY_ACT_CONSOLIDATED>
<WORK_ID_DOCUMENT type="data">
<VALUE>celex:02001R0999-20080115</VALUE>
</WORK_ID_DOCUMENT>
<DATE type="date">
<VALUE>2008-01-15</VALUE>
<YEAR>2008</YEAR>
<MONTH>01</MONTH>
<DAY>15</DAY>
</DATE>
<ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/a63b9e17-cc64-4d51-b4a8-1d7ef36f5f8e</VALUE>
<IDENTIFIER>a63b9e17-cc64-4d51-b4a8-1d7ef36f5f8e</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/32007R1428</VALUE>
<IDENTIFIER>32007R1428</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/oj/JOL_2007_317_R_0061_01</VALUE>
<IDENTIFIER>JOL_2007_317_R_0061_01</IDENTIFIER>
<TYPE>oj</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/reg/2007/1428/oj</VALUE>
<IDENTIFIER>reg:2007:1428:oj</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
</ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL>
<DATE_CREATION_LEGACY type="date">
<VALUE>2008-04-21</VALUE>
<YEAR>2008</YEAR>
<MONTH>04</MONTH>
<DAY>21</DAY>
</DATE_CREATION_LEGACY>
<WORK_CREATED_BY_AGENT type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/corporate-body/CONSIL</VALUE>
<IDENTIFIER>CONSIL</IDENTIFIER>
<TYPE>corporate-body</TYPE>
</URI>
<OP-CODE>CONSIL</OP-CODE>
<IDENTIFIER>CONSIL</IDENTIFIER>
<PREFLABEL>Council of the European Union</PREFLABEL>
<ALTLABEL>Council</ALTLABEL>
<ALTLABEL>Council of the European Communities</ALTLABEL>
</WORK_CREATED_BY_AGENT>
<ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/e103586f-27f9-4e54-9f11-df0c8f28e49a</VALUE>
<IDENTIFIER>e103586f-27f9-4e54-9f11-df0c8f28e49a</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/reg/2008/21(1)/oj</VALUE>
<IDENTIFIER>reg:2008:21(1):oj</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/oj/JOL_2008_009_R_0003_01</VALUE>
<IDENTIFIER>JOL_2008_009_R_0003_01</IDENTIFIER>
<TYPE>oj</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/32008R0021</VALUE>
<IDENTIFIER>32008R0021</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
</ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL>
<ACT_CONSOLIDATED_DATE type="date">
<VALUE>2008-01-15</VALUE>
<YEAR>2008</YEAR>
<MONTH>01</MONTH>
<DAY>15</DAY>
</ACT_CONSOLIDATED_DATE>
<RESOURCE_LEGAL_DATE_ENTRY-INTO-FORCE type="date">
<VALUE>2008-01-15</VALUE>
<YEAR>2008</YEAR>
<MONTH>01</MONTH>
<DAY>15</DAY>
</RESOURCE_LEGAL_DATE_ENTRY-INTO-FORCE>
<WORK_PART_OF_COLLECTION_DOCUMENT type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/document-collection/CONSLEG</VALUE>
<IDENTIFIER>CONSLEG</IDENTIFIER>
<TYPE>document-collection</TYPE>
</URI>
<OP-CODE>CONSLEG</OP-CODE>
<IDENTIFIER>CONSLEG</IDENTIFIER>
<PREFLABEL>CONSLEG</PREFLABEL>
</WORK_PART_OF_COLLECTION_DOCUMENT>
<RESOURCE_LEGAL_INFORMATION_MISCELLANEOUS type="data">
<VALUE>LASTMODIN {32008R0021|http://publications.europa.eu/resource/celex/32008R0021}</VALUE>
</RESOURCE_LEGAL_INFORMATION_MISCELLANEOUS>
<IDENTIFIER type="data">
<VALUE>613284</VALUE>
</IDENTIFIER>
<RESOURCE_LEGAL_YEAR type="data">
<VALUE>2001</VALUE>
</RESOURCE_LEGAL_YEAR>
<BASED_ON type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/cba1d322-3457-4545-a539-5b38936b3b15</VALUE>
<IDENTIFIER>cba1d322-3457-4545-a539-5b38936b3b15</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/32001R0999</VALUE>
<IDENTIFIER>32001R0999</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/oj/JOL_2001_147_R_0001_01</VALUE>
<IDENTIFIER>JOL_2001_147_R_0001_01</IDENTIFIER>
<TYPE>oj</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/reg/2001/999/oj</VALUE>
<IDENTIFIER>reg:2001:999:oj</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
</BASED_ON>
<RESOURCE_LEGAL_NUMBER_NATURAL_CELEX type="data">
<VALUE>0999</VALUE>
</RESOURCE_LEGAL_NUMBER_NATURAL_CELEX>
<YEAR type="data">
<VALUE>2001</VALUE>
</YEAR>
<LASTMODIFICATIONDATE type="date">
<VALUE>2016-06-30T23:26:35.867+02:00</VALUE>
<YEAR>2016</YEAR>
<MONTH>06</MONTH>
<DAY>30</DAY>
</LASTMODIFICATIONDATE>
<CREATED_BY type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/corporate-body/EP</VALUE>
<IDENTIFIER>EP</IDENTIFIER>
<TYPE>corporate-body</TYPE>
</URI>
<OP-CODE>EP</OP-CODE>
<IDENTIFIER>EP</IDENTIFIER>
<PREFLABEL>European Parliament</PREFLABEL>
<ALTLABEL>Common Assembly of the European Coal and Steel Community</ALTLABEL>
<ALTLABEL>Common Assembly</ALTLABEL>
<ALTLABEL>European Parliamentary Assembly</ALTLABEL>
<ALTLABEL>EP</ALTLABEL>
</CREATED_BY>
<IDENTIFIER type="data">
<VALUE>http://data.europa.eu/eli/reg/2001/999/2008-01-15</VALUE>
</IDENTIFIER>
<DATE_DOCUMENT type="date">
<VALUE>2008-01-15</VALUE>
<YEAR>2008</YEAR>
<MONTH>01</MONTH>
<DAY>15</DAY>
</DATE_DOCUMENT>
<IDENTIFIER type="data">
<VALUE>celex:02001R0999-20080115</VALUE>
</IDENTIFIER>
<ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/57907a3b-09c4-4984-b5bc-c2e2cf4700f8</VALUE>
<IDENTIFIER>57907a3b-09c4-4984-b5bc-c2e2cf4700f8</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/oj/JOL_2008_038_R_0032_01_REG_2007_727_32</VALUE>
<IDENTIFIER>JOL_2008_038_R_0032_01_REG_2007_727_32</IDENTIFIER>
<TYPE>oj</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/reg/2007/727/corrigendum/2008-02-13/oj</VALUE>
<IDENTIFIER>reg:2007:727:corrigendum:2008-02-13:oj</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/32007R0727R%2801%29</VALUE>
<IDENTIFIER>32007R0727R(01)</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
</ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL>
<ID_SECTOR type="data">
<VALUE>0</VALUE>
</ID_SECTOR>
<ACT_CONSOLIDATED_BASED_ON_RESOURCE_LEGAL type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/cba1d322-3457-4545-a539-5b38936b3b15</VALUE>
<IDENTIFIER>cba1d322-3457-4545-a539-5b38936b3b15</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/32001R0999</VALUE>
<IDENTIFIER>32001R0999</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/oj/JOL_2001_147_R_0001_01</VALUE>
<IDENTIFIER>JOL_2001_147_R_0001_01</IDENTIFIER>
<TYPE>oj</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/reg/2001/999/oj</VALUE>
<IDENTIFIER>reg:2001:999:oj</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
</ACT_CONSOLIDATED_BASED_ON_RESOURCE_LEGAL>
<ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/7272003b-b3ef-4412-84ea-4c87c2453acf</VALUE>
<IDENTIFIER>7272003b-b3ef-4412-84ea-4c87c2453acf</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/consolidation/2001R0999%2F20071102</VALUE>
<IDENTIFIER>2001R0999/20071102</IDENTIFIER>
<TYPE>consolidation</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/02001R0999-20071102</VALUE>
<IDENTIFIER>02001R0999-20071102</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/reg/2001/999/2007-11-02</VALUE>
<IDENTIFIER>reg:2001:999:2007-11-02</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
</ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL>
<ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/cba1d322-3457-4545-a539-5b38936b3b15</VALUE>
<IDENTIFIER>cba1d322-3457-4545-a539-5b38936b3b15</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/32001R0999</VALUE>
<IDENTIFIER>32001R0999</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/oj/JOL_2001_147_R_0001_01</VALUE>
<IDENTIFIER>JOL_2001_147_R_0001_01</IDENTIFIER>
<TYPE>oj</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/reg/2001/999/oj</VALUE>
<IDENTIFIER>reg:2001:999:oj</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
</ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL>
<WORK_CREATED_BY_AGENT type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/corporate-body/EP</VALUE>
<IDENTIFIER>EP</IDENTIFIER>
<TYPE>corporate-body</TYPE>
</URI>
<OP-CODE>EP</OP-CODE>
<IDENTIFIER>EP</IDENTIFIER>
<PREFLABEL>European Parliament</PREFLABEL>
<ALTLABEL>Common Assembly of the European Coal and Steel Community</ALTLABEL>
<ALTLABEL>Common Assembly</ALTLABEL>
<ALTLABEL>European Parliamentary Assembly</ALTLABEL>
<ALTLABEL>EP</ALTLABEL>
</WORK_CREATED_BY_AGENT>
<RESOURCE_LEGAL_ID_CELEX type="data">
<VALUE>02001R0999-20080115</VALUE>
</RESOURCE_LEGAL_ID_CELEX>
<WORK_ID_DOCUMENT type="data">
<VALUE>consolidation:2001R0999/20080115</VALUE>
</WORK_ID_DOCUMENT>
<RESOURCE_LEGAL_TYPE type="data">
<VALUE>R</VALUE>
</RESOURCE_LEGAL_TYPE>
<WORK_HAS_RESOURCE-TYPE type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/resource-type/CONS_TEXT</VALUE>
<IDENTIFIER>CONS_TEXT</IDENTIFIER>
<TYPE>resource-type</TYPE>
</URI>
<OP-CODE>CONS_TEXT</OP-CODE>
<IDENTIFIER>CONS_TEXT</IDENTIFIER>
<PREFLABEL>Consolidated text</PREFLABEL>
</WORK_HAS_RESOURCE-TYPE>
<RESOURCE_LEGAL_NUMBER_NATURAL type="data">
<VALUE>999</VALUE>
</RESOURCE_LEGAL_NUMBER_NATURAL>
<TYPE>cdm:act_consolidated</TYPE>
<TYPE>cdm:work</TYPE>
<TYPE>R</TYPE>
<TYPE>cdm:resource_legal</TYPE>
</WORK>
<EXPRESSION xmlns="">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/3e840d31-5c99-4a94-b91b-f24f9a45202b.0005</VALUE>
<IDENTIFIER>3e840d31-5c99-4a94-b91b-f24f9a45202b.0005</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/02001R0999-20080115.ENG</VALUE>
<IDENTIFIER>02001R0999-20080115.ENG</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/consolidation/2001R0999%2F20080115.ENG</VALUE>
<IDENTIFIER>2001R0999/20080115.ENG</IDENTIFIER>
<TYPE>consolidation</TYPE>
</URI>
</SAMEAS>
<TITLE type="data">
<VALUE>Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies</VALUE>
</TITLE>
<EXPRESSION_USES_LANGUAGE type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/language/ENG</VALUE>
<IDENTIFIER>ENG</IDENTIFIER>
<TYPE>language</TYPE>
</URI>
<OP-CODE>ENG</OP-CODE>
<IDENTIFIER>ENG</IDENTIFIER>
<PREFLABEL>English</PREFLABEL>
<ALTLABEL>English</ALTLABEL>
</EXPRESSION_USES_LANGUAGE>
<LANG type="data">
<VALUE>en</VALUE>
</LANG>
<LASTMODIFICATIONDATE type="date">
<VALUE>2014-10-10T10:39:21.639+02:00</VALUE>
<YEAR>2014</YEAR>
<MONTH>10</MONTH>
<DAY>10</DAY>
</LASTMODIFICATIONDATE>
<TITLE type="data">
<VALUE>CELEX1</VALUE>
</TITLE>
<EXPRESSION_TITLE type="data">
<VALUE>Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies</VALUE>
</EXPRESSION_TITLE>
<LANG type="data">
<VALUE>eng</VALUE>
</LANG>
</EXPRESSION>
</ukm:EURLexMetadata>
<ukm:UnappliedEffects>
<ukm:UnappliedEffect AppendedCommentary="2020 c. 1, Sch. 5 para. 1(1)" RequiresApplied="false" AffectedNumber="999" AffectingYear="2019" AffectingEffectsExtent="E+W+S+N.I." AffectingNumber="588" URI="http://www.legislation.gov.uk/id/effect/key-a29fe8c8f0832b5472425d553333ddad" AffectedYear="2001" AffectedURI="http://www.legislation.gov.uk/id/eur/2001/999" AffectingURI="http://www.legislation.gov.uk/id/uksi/2019/588" AffectingClass="UnitedKingdomStatutoryInstrument" AffectingProvisions="reg. 4(21)(a)(i)" EffectId="key-a29fe8c8f0832b5472425d553333ddad" Row="66" Comments="IP completion day" AffectedProvisions="Annex 3 Ch. A Pt. 2 point 4" Type="words substituted" AffectedClass="EuropeanUnionRegulation" Modified="2022-07-29T11:32:18Z" Notes="This amendment not applied to legislation.gov.uk. S.I. 2019/588, reg. 4(21)(a)(i) substituted immediately before IP completion day by S.I. 2020/1463, regs. 1(2)(a), 6(3)(g)">
<ukm:AffectedTitle>Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies</ukm:AffectedTitle>
<ukm:AffectedProvisions>
<ukm:Section Ref="annex-III-chapter-A" URI="http://www.legislation.gov.uk/id/eur/2001/999/annex/III/chapter/A">Annex 3 Ch. A </ukm:Section>
<ukm:Section Ref="annex-III-chapter-A-part-2" URI="http://www.legislation.gov.uk/id/eur/2001/999/annex/III/chapter/A/part/2" FoundRef="annex-III-chapter-A">Pt. 2</ukm:Section>
point 4
</ukm:AffectedProvisions>
<ukm:AffectingTitle>The Animals (Legislative Functions) (EU Exit) Regulations 2019</ukm:AffectingTitle>
<ukm:AffectingProvisions>
<ukm:Section Ref="regulation-4-21-a-i" URI="http://www.legislation.gov.uk/id/uksi/2019/588/regulation/4/21/a/i">reg. 4(21)(a)(i)</ukm:Section>
</ukm:AffectingProvisions>
<ukm:Savings>
<ukm:Section Ref="regulation-12" URI="http://www.legislation.gov.uk/id/uksi/2019/588/regulation/12">reg. 12</ukm:Section>
</ukm:Savings>
<ukm:CommencementAuthority>
<ukm:Section Ref="regulation-1" URI="http://www.legislation.gov.uk/id/uksi/2019/588/regulation/1">reg. 1</ukm:Section>
</ukm:CommencementAuthority>
<ukm:InForceDates>
<ukm:InForce Date="2020-12-31" Qualification="wholly in force"/>
</ukm:InForceDates>
</ukm:UnappliedEffect>
<ukm:UnappliedEffect AffectingYear="2019" AffectingNumber="170" Type="words omitted" AffectedYear="2001" AffectingURI="http://www.legislation.gov.uk/id/uksi/2019/170" AffectingClass="UnitedKingdomStatutoryInstrument" AffectedURI="http://www.legislation.gov.uk/id/eur/2001/999" AffectedNumber="999" URI="http://www.legislation.gov.uk/id/effect/key-2b2b05057ea6ebe7e0cbc092064e0b6c" RequiresApplied="false" Notes="This amendment not applied to legislation.gov.uk. Reg. 2(72)(b)(i) substituted immediately before IP completion day by S.I. 2020/1388, regs. 1(2)(a), 20(2)(w)" Modified="2022-07-29T11:32:18Z" AffectedClass="EuropeanUnionRegulation" AffectedProvisions="Annex 10 Ch. C point 3.2(c)(i)" AffectingEffectsExtent="E+W+S+N.I." EffectId="key-2b2b05057ea6ebe7e0cbc092064e0b6c" AppendedCommentary="2020 c. 1, Sch. 5 para. 1(1)" Comments="IP completion day" AffectingProvisions="reg. 2(72)(b)(i)" Row="369">
<ukm:AffectedTitle>Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies</ukm:AffectedTitle>
<ukm:AffectedProvisions>
<ukm:Section Ref="annex-X" URI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X">Annex 10 </ukm:Section>
<ukm:Section Ref="annex-X-chapter-C" URI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C">C</ukm:Section>
h. C point 3.2(c)(i)
</ukm:AffectedProvisions>
<ukm:AffectingTitle>The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019</ukm:AffectingTitle>
<ukm:AffectingProvisions>
<ukm:Section Ref="regulation-2-72-b-i" URI="http://www.legislation.gov.uk/id/uksi/2019/170/regulation/2/72/b/i">reg. 2(72)(b)(i)</ukm:Section>
</ukm:AffectingProvisions>
<ukm:CommencementAuthority>
<ukm:Section Ref="regulation-1" URI="http://www.legislation.gov.uk/id/uksi/2019/170/regulation/1">reg. 1</ukm:Section>
</ukm:CommencementAuthority>
<ukm:InForceDates>
<ukm:InForce Date="2020-12-31" Qualification="wholly in force"/>
</ukm:InForceDates>
</ukm:UnappliedEffect>
<ukm:UnappliedEffect AffectedClass="EuropeanUnionRegulation" AffectingClass="UnitedKingdomStatutoryInstrument" AffectedYear="2001" AppendedCommentary="2020 c. 1, Sch. 5 para. 1(1)" Type="omitted" Notes="This amendment not applied to legislation.gov.uk. S.I. 2019/588, reg. 4(16)(b) amended immediately before IP completion day by S.I. 2020/1463, regs. 1(2)(a), 6(3)(d)" EffectId="key-c7d2e41171d2367e64ccab3bd05f8a3d" URI="http://www.legislation.gov.uk/id/effect/key-c7d2e41171d2367e64ccab3bd05f8a3d" AffectedURI="http://www.legislation.gov.uk/id/eur/2001/999" Modified="2022-07-29T11:32:18Z" Row="539" AffectedNumber="999" AffectingEffectsExtent="E+W+S+N.I." AffectingNumber="588" Comments="IP completion day" AffectingURI="http://www.legislation.gov.uk/id/uksi/2019/588" RequiresApplied="false" AffectingProvisions="reg. 4(16)(b)" AffectedProvisions="Art. 23a(f)" AffectingYear="2019">
<ukm:AffectedTitle>Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies</ukm:AffectedTitle>
<ukm:AffectedProvisions>
<ukm:Section Ref="article-23a-f" URI="http://www.legislation.gov.uk/id/eur/2001/999/article/23a/f" FoundRef="article-23a">Art. 23a(f)</ukm:Section>
</ukm:AffectedProvisions>
<ukm:AffectingTitle>The Animals (Legislative Functions) (EU Exit) Regulations 2019</ukm:AffectingTitle>
<ukm:AffectingProvisions>
<ukm:Section Ref="regulation-4-16-b" URI="http://www.legislation.gov.uk/id/uksi/2019/588/regulation/4/16/b">reg. 4(16)(b)</ukm:Section>
</ukm:AffectingProvisions>
<ukm:Savings>
<ukm:Section Ref="regulation-12" URI="http://www.legislation.gov.uk/id/uksi/2019/588/regulation/12">reg. 12</ukm:Section>
</ukm:Savings>
<ukm:CommencementAuthority>
<ukm:Section Ref="regulation-1" URI="http://www.legislation.gov.uk/id/uksi/2019/588/regulation/1">reg. 1</ukm:Section>
</ukm:CommencementAuthority>
<ukm:InForceDates>
<ukm:InForce Date="2020-12-31" Qualification="wholly in force"/>
</ukm:InForceDates>
</ukm:UnappliedEffect>
<ukm:UnappliedEffect AffectingClass="UnitedKingdomStatutoryInstrument" EffectId="key-cac987a5cc8477fc669311b97c29e76d" Row="960" Modified="2023-02-28T19:30:52Z" AffectedClass="EuropeanUnionRegulation" RequiresApplied="false" Notes="This amendment not applied to legislation.gov.uk. Operative words in reg. 2(2)(b) omitted immediately before IP completion day by S.I. 2020/1388, regs. 1(2)(a), 20(2)(a)(ii)(bb)" AffectedProvisions="Art. 3(1B)(c)" AffectingTerritorialApplication="E+W+S" AffectingProvisions="reg. 20(2)(a)(ii)(bb)" AffectingYear="2020" AffectingNumber="1388" URI="http://www.legislation.gov.uk/id/effect/key-cac987a5cc8477fc669311b97c29e76d" AffectedURI="http://www.legislation.gov.uk/id/eur/2001/999" AffectedNumber="999" AffectingEffectsExtent="E+W+S+N.I." Comments="IP completion day - art. 3(1B)(c) omitted prior to art. 3(1B) being inserted" AffectingURI="http://www.legislation.gov.uk/id/uksi/2020/1388" AffectedYear="2001" Type="omitted in earlier amending S.I. 2019/170, reg. 2(2)(b)">
<ukm:AffectedTitle>Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies</ukm:AffectedTitle>
<ukm:AffectedProvisions>
<ukm:Section Ref="article-3-1B-c" URI="http://www.legislation.gov.uk/id/eur/2001/999/article/3/1B/c" FoundRef="article-3">Art. 3(1B)(c)</ukm:Section>
</ukm:AffectedProvisions>
<ukm:AffectingTitle>The Animals, Aquatic Animal Health, Invasive Alien Species, Plant Propagating Material and Seeds (Amendment) (EU Exit) Regulations 2020</ukm:AffectingTitle>
<ukm:AffectingProvisions>
<ukm:Section Ref="regulation-20-2-a-ii-bb" URI="http://www.legislation.gov.uk/id/uksi/2020/1388/regulation/20/2/a/ii/bb" FoundRef="regulation-20">reg. 20(2)(a)(ii)(bb)</ukm:Section>
</ukm:AffectingProvisions>
<ukm:CommencementAuthority>
<ukm:Section Ref="regulation-1-2-a" URI="http://www.legislation.gov.uk/id/uksi/2020/1388/regulation/1/2/a">reg. 1(2)(a)</ukm:Section>
</ukm:CommencementAuthority>
<ukm:InForceDates>
<ukm:InForce Date="2020-12-31" Qualification="wholly in force"/>
</ukm:InForceDates>
</ukm:UnappliedEffect>
</ukm:UnappliedEffects>
</ukm:EUMetadata>
<ukm:Alternatives>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_adopted_en.pdf" Date="2001-05-22" Size="311160"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2001-07-01_en.pdf" Date="2001-07-01" Size="202714" Revised="2001-07-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2001-10-01_en.pdf" Date="2001-10-01" Size="205056" Revised="2001-10-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2002-01-01_en.pdf" Date="2002-01-01" Size="213407" Revised="2002-01-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2002-03-01_en.pdf" Date="2002-03-01" Size="215816" Revised="2002-03-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2002-04-01_en.pdf" Date="2002-04-01" Size="210422" Revised="2002-04-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2002-08-25_en.pdf" Date="2002-08-25" Size="212357" Revised="2002-08-25"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2003-03-05_en.pdf" Date="2003-03-05" Size="214284" Revised="2003-03-05"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2003-10-01_en.pdf" Date="2003-10-01" Size="243052" Revised="2003-10-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2003-11-03_en.pdf" Date="2003-11-03" Size="244895" Revised="2003-11-03"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2003-11-05_en.pdf" Date="2003-11-05" Size="246819" Revised="2003-11-05"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2004-01-01_en.pdf" Date="2004-01-01" Size="244040" Revised="2004-01-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2004-05-01_en.pdf" Date="2004-05-01" Size="248791" Revised="2004-05-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2004-07-01_en.pdf" Date="2004-07-01" Size="249886" Revised="2004-07-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2005-01-01_en.pdf" Date="2005-01-01" Size="274694" Revised="2005-01-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2005-02-11_en.pdf" Date="2005-02-11" Size="283376" Revised="2005-02-11"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2005-03-09_en.pdf" Date="2005-03-09" Size="285822" Revised="2005-03-09"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2005-07-01_en.pdf" Date="2005-07-01" Size="285963" Revised="2005-07-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2005-09-01_en.pdf" Date="2005-09-01" Size="285137" Revised="2005-09-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2006-01-01_en.pdf" Date="2006-01-01" Size="279712" Revised="2006-01-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2006-03-17_en.pdf" Date="2006-03-17" Size="331137" Revised="2006-03-17"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2006-05-25_en.pdf" Date="2006-05-25" Size="331793" Revised="2006-05-25"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2006-07-09_en.pdf" Date="2006-07-09" Size="332945" Revised="2006-07-09"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2007-01-19_en.pdf" Date="2007-01-19" Size="302900" Revised="2007-01-19"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2007-07-17_en.pdf" Date="2007-07-17" Size="283293" Revised="2007-07-17"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2007-11-02_en.pdf" Date="2007-11-02" Size="285775" Revised="2007-11-02"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2008-01-15_en.pdf" Date="2008-01-15" Size="286230" Revised="2008-01-15"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2008-04-26_en.pdf" Date="2008-04-26" Size="294091" Revised="2008-04-26"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2008-07-10_en.pdf" Date="2008-07-10" Size="296251" Revised="2008-07-10"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2008-09-29_en.pdf" Date="2008-09-29" Size="296236" Revised="2008-09-29"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2008-10-20_en.pdf" Date="2008-10-20" Size="300824" Revised="2008-10-20"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2009-02-24_en.pdf" Date="2009-02-24" Size="311521" Revised="2009-02-24"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2009-03-19_en.pdf" Date="2009-03-19" Size="311551" Revised="2009-03-19"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2009-04-20_en.pdf" Date="2009-04-20" Size="314479" Revised="2009-04-20"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2011-01-01_en.pdf" Date="2011-01-01" Size="1167598" Revised="2011-01-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2011-03-18_en.pdf" Date="2011-03-18" Size="1170663" Revised="2011-03-18"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2012-11-17_en.pdf" Date="2012-11-17" Size="1193283" Revised="2012-11-17"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2013-06-01_en.pdf" Date="2013-06-01" Size="1221815" Revised="2013-06-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2013-07-01_en.pdf" Date="2013-07-01" Size="1273046" Revised="2013-07-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2015-01-01_en.pdf" Date="2015-01-01" Size="1283121" Revised="2015-01-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2015-05-27_en.pdf" Date="2015-05-27" Size="801414" Revised="2015-05-27"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2015-08-05_en.pdf" Date="2015-08-05" Size="802260" Revised="2015-08-05"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2016-02-03_en.pdf" Date="2016-02-03" Size="811736" Revised="2016-02-03"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2016-09-08_en.pdf" Date="2016-09-08" Size="908579" Revised="2016-09-08"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2017-02-13_en.pdf" Date="2017-02-13" Size="967121" Revised="2017-02-13"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2017-05-17_en.pdf" Date="2017-05-17" Size="925891" Revised="2017-05-17"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2017-07-01_en.pdf" Date="2017-07-01" Size="965621" Revised="2017-07-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2017-11-20_en.pdf" Date="2017-11-20" Size="999641" Revised="2017-11-20"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2018-01-01_en.pdf" Date="2018-01-01" Size="1023245" Revised="2018-01-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2018-07-30_en.pdf" Date="2018-07-30" Size="1002295" Revised="2018-07-30"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2019-01-01_en.pdf" Date="2019-01-01" Size="1054960" Revised="2019-01-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2019-03-20_en.pdf" Date="2019-03-20" Size="1016287" Revised="2019-03-20"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2019-07-17_en.pdf" Date="2019-07-17" Size="1124324" Revised="2019-07-17"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2019-12-14_en.pdf" Date="2019-12-14" Size="1104135" Revised="2019-12-14"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2020-07-02_en.pdf" Date="2020-07-02" Size="1178486" Revised="2020-07-02"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eur/2001/999/pdfs/eur_20010999_2020-11-19_en.pdf" Date="2020-11-19" Size="1150675" Revised="2020-11-19"/>
</ukm:Alternatives>
<ukm:Statistics>
<ukm:TotalParagraphs Value="262"/>
<ukm:BodyParagraphs Value="29"/>
<ukm:ScheduleParagraphs Value="233"/>
<ukm:AttachmentParagraphs Value="0"/>
<ukm:TotalImages Value="0"/>
</ukm:Statistics>
</ukm:Metadata>
<EURetained>
<Schedules RestrictStartDate="2008-01-15" RestrictEndDate="2008-04-26" RestrictExtent="E+W+S+N.I.">
<Schedule DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X" RestrictEndDate="2008-04-26" id="annex-X" RestrictStartDate="2008-01-15" RestrictExtent="E+W+S+N.I.">
<Number>ANNEX X</Number>
<TitleBlock>
<Title>REFERENCE LABORATORIES, SAMPLING AND LABORATORY ANALYSIS METHODS</Title>
</TitleBlock>
<ScheduleBody>
<EUChapter DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C" RestrictEndDate="2008-04-26" id="annex-X-chapter-C" RestrictStartDate="2008-01-15" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">CHAPTER C</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Sampling and laboratory testing</Substitution>
</Title>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/1/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/1" RestrictEndDate="2015-01-01" id="annex-X-chapter-C-division-1" RestrictStartDate="2007-07-17" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O024001M016" CommentaryRef="c000005">1.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O024001M016" CommentaryRef="c000005">Sampling</Substitution>
</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O024001M016" CommentaryRef="c000005">Any samples intended to be examined for the presence of a TSE shall be collected using the methods and protocols laid down in the latest edition of the Manual for diagnostic tests and vaccines for Terrestrial Animals of the International Office for Epizooties (IOE/OIE) (the Manual). In addition, or in the absence, of OIE methods and protocols, and to ensure that sufficient material is available, the competent authority shall ensure the use of sampling methods and protocols in accordance with guidelines issued by the Community Reference Laboratory. In particular the competent authority shall collect the appropriate tissues, according to the available scientific advice and the guidelines of the Community Reference Laboratory, in order to ensure the detection of all known strains of TSE in small ruminants and shall keep at least half of the collected tissues fresh but not frozen until the result of the rapid test is negative. Where the result is positive or inconclusive the residual tissues must be processed in accordance with the Community reference laboratory guidelines.</Substitution>
</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O024001M016" CommentaryRef="c000005">The samples shall be correctly marked as to the identity of the sampled animal.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/2/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/2" id="annex-X-chapter-C-division-2" RestrictStartDate="2005-02-11" RestrictEndDate="2015-01-01" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">2.</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Laboratories</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Any laboratory examination for TSE shall be carried out in laboratories approved for that purpose by the competent authority.</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/3/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/3" RestrictEndDate="2009-03-19" id="annex-X-chapter-C-division-3" RestrictStartDate="2007-07-17" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">3.</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Methods and protocols</Substitution>
</Title>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/3/division/3.1/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/3/division/3.1" RestrictEndDate="2009-03-19" id="annex-X-chapter-C-division-3-division-3.1" RestrictStartDate="2005-02-11" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">3.1.</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Laboratory testing for the presence of BSE in bovine animals</Substitution>
</Title>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/3/division/3.1/division/a/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/3/division/3.1/division/a" RestrictEndDate="2009-03-19" id="annex-X-chapter-C-division-3-division-3.1-division-a" RestrictStartDate="2005-02-11" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">(a)</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Suspect cases</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Samples from bovine animals sent for laboratory testing pursuant to the provisions of Article 12(2) shall be subject to a histopathological examination as laid down in the latest edition of the Manual, except where the material is autolysed. Where the result of the histopathological examination is inconclusive or negative or where the material is autolysed, the tissues shall be subjected to an examination by one of the other diagnostic methods laid down in the Manual (immunocytochemistry, immuno-blotting or demonstration of characteristic fibrils by electron microscopy). However, rapid tests cannot be used for this purpose.</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">If the result of one of those examinations is positive, the animals shall be regarded a positive BSE case.</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/3/division/3.1/division/b/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/3/division/3.1/division/b" RestrictEndDate="2009-03-19" id="annex-X-chapter-C-division-3-division-3.1-division-b" RestrictStartDate="2005-02-11" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">(b)</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">BSE monitoring</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Samples from bovine animals sent for laboratory testing pursuant to the provisions of Annex III, Chapter A, Part I (Monitoring in bovine animals) shall be examined by a rapid test.</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">When the result of the rapid test is inconclusive or positive, the sample shall immediately be subject to confirmatory examinations in an official laboratory. The confirmatory examination shall start by a histopathological examination of the brainstem as laid down in the latest edition of the Manual, except where the material is autolysed or otherwise not suitable for examination by histopathology. Where the result of the histopathological examination is inconclusive or negative or where the material is autolysed, the sample shall be subjected to an examination by one of the other diagnostic methods referred to in (a).</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">An animal shall be regarded a positive BSE case, if the result of the rapid test is positive or inconclusive, and either</Substitution>
</Text>
</P>
<P>
<UnorderedList Decoration="dash">
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">the result of the subsequent histopathological examination is positive, or</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">the result of another diagnostic method referred to in (a) is positive.</Substitution>
</Text>
</Para>
</ListItem>
</UnorderedList>
</P>
</Division>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/3/division/3.2/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/3/division/3.2" RestrictEndDate="2009-03-19" id="annex-X-chapter-C-division-3-division-3.2" RestrictStartDate="2007-07-17" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">3.2.</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Laboratory testing for the presence of TSE in ovine and caprine animals</Substitution>
</Title>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/3/division/3.2/division/a/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/3/division/3.2/division/a" id="annex-X-chapter-C-division-3-division-3.2-division-a" RestrictStartDate="2005-02-11" RestrictEndDate="2009-03-19" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">(a)</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Suspect cases</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Samples from ovine and caprine animals sent for laboratory testing pursuant to the provisions of Article 12(2) shall be subject to a histopathological examination as laid down in the latest edition of the Manual, except where the material is autolysed. Where the result of the histopathological examination is inconclusive or negative or where the material is autolysed, the sample shall be subjected to an examination by immunocytochemistry, immuno-blotting or demonstration of characteristic fibrils by electron microscopy, as laid down in the Manual. However, rapid tests cannot be used for this purpose.</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">If the result of one of those examinations is positive, the animal shall be regarded a positive scrapie case.</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/3/division/3.2/division/b/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/3/division/3.2/division/b" RestrictEndDate="2015-01-01" id="annex-X-chapter-C-division-3-division-3.2-division-b" RestrictStartDate="2007-07-17" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O024001M017" CommentaryRef="c000005">(b)</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O024001M017" CommentaryRef="c000005">TSE monitoring</Substitution>
</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O024001M017" CommentaryRef="c000005">Samples from ovine and caprine animals sent for laboratory testing pursuant to the provisions of Annex III, Chapter A, Part II (Monitoring in ovine and caprine animals) shall be examined by a rapid test using the appropriate methods and protocols, according to the available scientific advice and the guidelines of the Community Reference Laboratory, in order to ensure the detection of all known strains of TSE.</Substitution>
</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O024001M017" CommentaryRef="c000005">When the result of the rapid test is inconclusive or positive, the sampled tissues shall immediately be sent to an official laboratory for confirmatory examinations by immunocytochemistry, immuno-blotting or demonstration of characteristic fibrils by electron microscopy, as referred to in (a). If the result of the confirmatory examination is negative or inconclusive, additional confirmatory testing shall be carried out according the guidelines of the Community reference laboratory.</Substitution>
</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O024001M017" CommentaryRef="c000005">If the result of one of the confirmatory examination is positive, the animal shall be regarded a positive TSE case.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/3/division/3.2/division/c/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/3/division/3.2/division/c" RestrictEndDate="2009-03-19" id="annex-X-chapter-C-division-3-division-3.2-division-c" RestrictStartDate="2007-07-17" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">(c)</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Further examination of positive scrapie cases</Substitution>
</Title>
<P>
<OrderedList Type="roman" Decoration="parens">
<ListItem NumberOverride="(i)">
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Primary molecular testing with a discriminatory immuno-blotting</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Samples from clinical suspect cases and from animals tested in accordance with Annex III, Chapter A, Part II, points 2 and 3 which are regarded as positive scrapie cases following the examinations referred to in points (a) or (b), or which display characteristics which are deemed by the testing laboratory to merit investigation, shall be forwarded for further examination by a primary molecular typing method to:</Substitution>
</Text>
</Para>
<Para>
<UnorderedList Decoration="dash">
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Agence Française de Sécurité Sanitaire des Aliments, Laboratoire de pathologie bovine, 31, avenue Tony Garnier, BP 7033, F-69342, Lyon Cedex, France</Substitution>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">, or</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Veterinary Laboratories Agency, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom</Substitution>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">, or</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">to a laboratory, appointed by the competent authority, which has participated successfully in proficiency testing organised by the Community Reference Laboratory for the use of a molecular typing method, or</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">on a provisional basis until </Substitution>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">1 May 2005</Substitution>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">, the laboratories approved for this purpose by the CRL panel of experts.</Substitution>
</Text>
</Para>
</ListItem>
</UnorderedList>
</Para>
</ListItem>
<ListItem NumberOverride="(ii)">
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Ring trial with additional molecular testing methods</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Samples from scrapie cases in which the presence of BSE cannot be excluded according to the guidelines issued by the Community Reference Laboratory by the primary molecular testing referred to in (i), shall be forwarded immediately to the laboratories listed in point (d) after consultation with the Community Reference Laboratory, and with all the relevant information available. They shall be submitted to a ring trial with at least:</Substitution>
</Text>
</Para>
<Para>
<UnorderedList Decoration="dash">
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">a second discriminatory immuno-blotting,</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">a discriminatory immunocytochemistry, and</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">a discriminatory ELISA (Enzyme linked ImmunoSorbent Assay)</Substitution>
</Text>
</Para>
</ListItem>
</UnorderedList>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O024001M018" CommentaryRef="c000005">Further testing of positive TSE samples detected in infected flocks on the same holding shall be carried out at least on the first two positive TSE cases detected every year following the index case.</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
</OrderedList>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">The results shall be interpreted by the Community Reference Laboratory assisted by a panel of experts including a representative of the relevant National Reference Laboratory. The Commission shall be informed immediately about the outcome of that interpretation. Samples indicative for BSE by three different methods and samples inconclusive in the ring trial shall be further analysed by a mouse bioassay for final confirmation.</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Further testing of samples taken from infected flocks on the same holding in accordance with the provisions of Annex III, Chapter A, Part II, point 5, shall be carried out in accordance with the advice of the Community Reference Laboratory, after consultation with the relevant National Reference Laboratory.</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/3/division/3.2/division/d/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/3/division/3.2/division/d" id="annex-X-chapter-C-division-3-division-3.2-division-d" RestrictStartDate="2005-02-11" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">(d)</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Laboratories approved for performing further examination by molecular typing methods</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">The laboratories approved for further molecular typing are:</Substitution>
</Text>
</P>
<P>
<UnorderedList Decoration="none">
<ListItem>
<Para>
<BlockText>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Agence Française de Sécurité Sanitaire des Aliments</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Laboratoire de pathologie bovine</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">31, avenue Tony Garnier</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">BP 7033</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">F-69342 Lyon Cedex</Substitution>
</Text>
</Para>
</BlockText>
</Para>
</ListItem>
<ListItem>
<Para>
<BlockText>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Centre CEA Fontenay-aux-Roses, BP 6</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">F-92265 Fontenay-aux-Roses Cedex</Substitution>
</Text>
</Para>
</BlockText>
</Para>
</ListItem>
<ListItem>
<Para>
<BlockText>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Service de Pharmacologie et d’Immunologie</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Centre CEA Saclay, bâtiment 136</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">F-91191 Gif-sur-Yvette Cedex</Substitution>
</Text>
</Para>
</BlockText>
</Para>
</ListItem>
<ListItem>
<Para>
<BlockText>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Veterinary Laboratories Agency</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Woodham Lane</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">New Haw</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Addlestone</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Surrey KT15 3NB</Substitution>
</Text>
</Para>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">United Kingdom</Substitution>
</Text>
</Para>
</BlockText>
</Para>
</ListItem>
</UnorderedList>
</P>
</Division>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/3/division/3.3/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/3/division/3.3" RestrictEndDate="2015-01-01" id="annex-X-chapter-C-division-3-division-3.3" RestrictStartDate="2005-02-11" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">3.3.</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Laboratory testing for the presence of TSEs in species other than those referred to in points 3.1. and 3.2.</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Where methods and protocols are established for tests carried out to confirm the suspected presence of a TSE in a species other than bovine, ovine and caprine, they shall include at least a histopathological examination of brain tissue. The competent authority may also require laboratory tests such as immunocytochemistry, immuno-blotting, demonstration of characteristic fibrils by electron microscopy or other methods designed to detect the disease associated form of the prion protein. In any case at least one other laboratory examination shall be carried out if the initial histopathological examination is negative or inconclusive. At least three different examinations shall be carried out in the event of the first appearance of the disease.</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">In particular, where BSE is suspected in a species other than bovine animals, samples shall be submitted for strain-typing, where possible.</Substitution>
</Text>
</P>
</Division>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/4/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/4" RestrictEndDate="2008-04-26" id="annex-X-chapter-C-division-4" RestrictStartDate="2008-01-15" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">4.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Rapid tests</Substitution>
</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">For the purposes of carrying out the rapid tests in accordance with Articles 5(3) and 6(1), the following methods shall be used as rapid tests for the monitoring of BSE in bovine animals:</Substitution>
</Substitution>
</Text>
</P>
<P>
<UnorderedList Decoration="dash">
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">immuno-blotting test based on a Western blotting procedure for the detection of the Proteinase K resistant fragment PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Res</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> (Prionics-Check Western test),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">chemiluminescent ELISA test involving an extraction procedure and an ELISA technique, using an enhanced chemiluminescent reagent (Enfer test & Enfer TSE Kit version 2.0, automated sample preparation),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">microplate based immunoassay for the detection of PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Sc</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> (Enfer TSE Version 3),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">sandwich immunoassay for PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Res</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> carried out following denaturation and concentration steps (Bio-Rad Te-SeE test),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">microplate based immunoassay (ELISA) which detects Proteinase K resistant PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Res</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> with monoclonal antibodies (Prionics-Check LIA test),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">conformation-dependent immunoassay, BSE antigen test kit (Beckman Coulter InPro CDI kit),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">chemiluminescent ELISA for qualitative determination of PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Sc</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> (CediTect BSE test),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">immunoassay using a chemical polymer for selective PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Sc</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> capture and a monoclonal detection antibody directed against conserved regions of the PrP molecule (IDEXX HerdChek BSE Antigen Test Kit, EIA),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">microplate based chemiluminescent immunoassay for the detection of PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Sc</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> in bovine tissues (Institut Pourquier Speed’it BSE),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">lateral flow immunoassay using two different monoclonal antibodies to detect Proteinase K resistant PrP fractions (Prionics Check PrioSTRIP),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">two-sided immunoassay using two different monoclonal antibodies directed against two epitopes presented in a highly unfolded state of bovine PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Sc</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> (Roboscreen Beta Prion BSE EIA Test Kit),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">sandwich ELISA for the detection of Proteinase K resistant PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Sc</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> (Roche Applied Science PrionScreen),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">antigen-capture ELISA using two different monocloncal antibodies to detect Proteinase K resistant PrP fractions (Fujirebio FRELISA BSE </Substitution>
</Substitution>
<Emphasis>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">post-mortem</Substitution>
</Substitution>
</Emphasis>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> rapid BSE Test).</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
</UnorderedList>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">For the purposes of carrying out the rapid tests in accordance with Articles 5(3) and 6(1), the following methods shall be used as rapid tests for the monitoring of TSEs in ovine and caprine animals:</Substitution>
</Substitution>
</Text>
</P>
<P>
<UnorderedList Decoration="dash">
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">conformation-dependent immunoassay, BSE antigen test kit (Beckman Coulter InPro CDI kit),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">sandwich immunoassay for PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Res</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> carried out following denaturation and concentration steps (Bio-Rad Te-SeE test),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">sandwich immunoassay for PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Res</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> carried out following denaturation and concentration steps (Bio-Rad Te-SeE Sheep/Goat test),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">chemiluminescent ELISA test involving an extraction procedure and an ELISA technique, using an enhanced chemiluminescent reagent (Enfer TSE Kit Version 2.0),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">microplate based immunoassay for the detection of PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Sc</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> (Enfer TSE Version 3),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">immunoassay using a chemical polymer for selective PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Sc</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> capture and a monoclonal detection antibody directed against conserved regions of the PrP molecule (IDEXX HerdChek BSE-Scrapie Antigen Test Kit, EIA),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">microplate based chemiluminescent immunoassay for the detection of PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Sc</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> in ovine tissues (POURQUIER’S-LIA Scrapie),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">immuno-blotting test based on a Western blotting procedure for the detection of the Proteinase K resistant fragment PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Res</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> (Prionics-Check Western Small Ruminant test),</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">microplate based chemiluminescent immunoassay for the detection of Proteinase K resistant PrP</Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Sc</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024"> (Prionics Check LIA Small Ruminants).</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
</UnorderedList>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">In the case of all tests, sample tissue to which the test is to be applied must comply with the manufacturer’s instructions for use.</Substitution>
</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">The producer of the rapid tests must have put in place a quality assurance system, approved by the Community Reference Laboratory (CRL) that ensures that the test performance does not change. The producer must provide the test protocol to the CRL.</Substitution>
</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">
<Substitution ChangeId="O026001M003" CommentaryRef="c000024">Changes to rapid tests and to test protocols may be made only after prior notification to the CRL and provided that the CRL finds that the change does not alter the sensitivity, specificity or reliability of the rapid test. That finding shall be communicated to the Commission and to the national reference laboratories.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eur/2001/999/annex/X/chapter/C/division/5/2008-01-15" IdURI="http://www.legislation.gov.uk/id/eur/2001/999/annex/X/chapter/C/division/5" id="annex-X-chapter-C-division-5" RestrictStartDate="2005-02-11" RestrictEndDate="2015-01-01" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">5.</Substitution>
</Number>
<Title>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">Alternative tests</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O015001M004" CommentaryRef="c000010">(To be defined)</Substitution>
</Text>
</P>
</Division>
</EUChapter>
</ScheduleBody>
</Schedule>
</Schedules>
</EURetained>
<Commentaries>
<Commentary Type="F" Source="EU" id="c000005">
<Para>
<Text>
Substituted by
<Citation Class="EuropeanUnionRegulation" Year="2007" Number="727" URI="http://www.legislation.gov.uk/id/eur/2007/727" Title="Commission Regulation (EC) No 727/2007 of 26 June 2007 amending Annexes I, III, VII and X to Regulation (EC) No 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance)">Commission Regulation (EC) No 727/2007 of 26 June 2007 amending Annexes I, III, VII and X to Regulation (EC) No 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance)</Citation>
.
</Text>
</Para>
</Commentary>
<Commentary Type="F" Source="EU" id="c000010">
<Para>
<Text>
Substituted by
<Citation Class="EuropeanUnionRegulation" Year="2005" Number="36" URI="http://www.legislation.gov.uk/id/eur/2005/36" Title="Commission Regulation (EC) No 36/2005 of 12 January 2005 amending Annexes III and X to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards epidemio-surveillance for transmissible spongiform encephalopathies in bovine, ovine and caprine animals (Text with EEA relevance)">Commission Regulation (EC) No 36/2005 of 12 January 2005 amending Annexes III and X to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards epidemio-surveillance for transmissible spongiform encephalopathies in bovine, ovine and caprine animals (Text with EEA relevance)</Citation>
.
</Text>
</Para>
</Commentary>
<Commentary Type="F" Source="EU" id="c000024">
<Para>
<Text>
Substituted by
<Citation Class="EuropeanUnionRegulation" Year="2008" Number="21" URI="http://www.legislation.gov.uk/id/eur/2008/21" Title="Commission Regulation (EC) No 21/2008 of 11 January 2008 amending Annex X to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards the lists of rapid tests (Text with EEA relevance)">Commission Regulation (EC) No 21/2008 of 11 January 2008 amending Annex X to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards the lists of rapid tests (Text with EEA relevance)</Citation>
.
</Text>
</Para>
</Commentary>
</Commentaries>
</Legislation>